Abstract
Objective: The objective of the study was to describe the process of implementing a technology system to improve safety and quality in all the processes involved in the treatment with parenteral antineoplastic agents within an interdisciplinary team and to analyze the errors detected and avoided by this system.
Materials and Methods: This is an observational and retrospective study, where the implementation of an expert technology system in all phases of the therapeutic process is described, including: prescription, validation, preparation and administration of drugs. This system integrates a qualitative and quantitative control (with an optical codes reader and a gravimetric method). All the administration process was also observed and controlled. A descriptive analysis of the errors recorded in the various stages of the process was carried out during 3 months. Results: There were a total of 2185 drugs prescribed and prepared, belonging to 382 patients. 14 prescription errors were recorded, representing 0.6% of admixtures. All were potential errors that the system helped to avoid and did not reach the patient. Qualitative control results: a total of 93(4.2%) incorrect code readings were detected and 16(0.7%) readings for wrong components / wrong drugs. Explaining the results of quantitative control, 95 mixtures (4.3%) were prepared incorrectly -29(1.3%) due to an overdosage, and 66(3.0%) because of an underdosage. Conclusion: A new support technology was introduced to increase pharmacotherapeutic security in oncohematology, which successfully achieved the purpose in all stages of the process. In the study period, the implemented system successfully intercepted all the errors that could have reached the patient in 6.2% of the prescribed mixtures.Keywords: Antineoplastic agent, electronic prescription, gravimetric control, oncohematology, pharmacotherapy, safety, technology system.
Graphical Abstract
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Drug Targets
Current Neuropharmacology
Current Pharmaceutical Design
Current Pharmaceutical Analysis
Current Vascular Pharmacology
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Related Books
Frontiers in Drug Design and Discovery
New Findings from Natural Substances
Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II
Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I
Pharmaceutical Chemistry and Production: An Introductory Textbook
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceuticals for Targeting Coronaviruses
Frontiers in Cardiovascular Drug Discovery
Frontiers in Drug Design and Discovery
Medical Applications of Beta-Glucan
30
1